Thomas M Nelson
Electrical Contractor in Trenton, NJ
License number
New Jersey 34LS00023600
Issued Date
Mar 19, 2005
Expiration Date
Aug 31, 2019
Category
Electrical Contractors
Type
Locksmith License
Address
Address
Trenton, NJ
Professional information
Method Of Diagnosing Lung Cancer Using Bgs42
US Patent:
7741025, Jun 22, 2010
Filed:
Sep 10, 2007
Appl. No.:
11/900344
Inventors:
John N. Feder - Belle Mead NJ, US
Shujian Wu - Langhorne PA, US
Thomas C. Nelson - Lawrenceville NJ, US
Liana M. Lee - San Francisco CA, US
Shujian Wu - Langhorne PA, US
Thomas C. Nelson - Lawrenceville NJ, US
Liana M. Lee - San Francisco CA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C12Q 1/70, C12Q 1/68
US Classification:
435 5, 435 6
Abstract:
The present invention provides novel polynucleotides encoding BGS-42 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel BGS-42 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
Methods Of Diagnosing Colon Adenocarcinoma Using Mrna Encoding The Human G-Protein Coupled Receptor, Hgprbmy23
US Patent:
7713699, May 11, 2010
Filed:
Aug 31, 2007
Appl. No.:
11/897997
Inventors:
John N. Feder - Belle Mead NJ, US
Thomas C. Nelson - Lawrenceville NJ, US
Chandra S. Ramanathan - Ringoes NJ, US
Rolf-Peter Ryseck - Ewing NJ, US
Michael G. Kornacker - Princeton NJ, US
Thomas C. Nelson - Lawrenceville NJ, US
Chandra S. Ramanathan - Ringoes NJ, US
Rolf-Peter Ryseck - Ewing NJ, US
Michael G. Kornacker - Princeton NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C12N 1/68, G01N 33/48, C07K 14/705
US Classification:
435 6, 436 63, 436 64, 436 94
Abstract:
The present invention provides novel polynucleotides encoding HGPRBMY23 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel HGPRBMY23 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly renal diseases and/or disorders, colon cancer, breast cancer, and diseases and disorders related to aberrant NFKB modulation. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
Novel Human G-Protein Coupled Receptor, Hgprbmy11, Expressed Highly In Heart And Variants Thereof
US Patent:
2003015, Aug 14, 2003
Filed:
Nov 16, 2001
Appl. No.:
09/991225
Inventors:
John Feder - Belle Mead NJ, US
Thomas Nelson - Lawrenceville NJ, US
Chandra Ramanathan - Wallingford CT, US
Angela Cacace - Clinton CT, US
Lauren Barber - Griswood CT, US
Thomas Nelson - Lawrenceville NJ, US
Chandra Ramanathan - Wallingford CT, US
Angela Cacace - Clinton CT, US
Lauren Barber - Griswood CT, US
International Classification:
C12N009/64, C12Q001/68, C07H021/04, C12P021/02, C12N005/06
US Classification:
435/226000, 435/006000, 435/069100, 435/325000, 435/320100, 536/023200
Abstract:
The present invention provides novel polynucleotides encoding HGPRBMY11 polypeptides, fragments and homologues thereof. The present invention also provides polynucleotides encoding variants of the HGPRBMY11 polypeptide, HGPRBMY11v1 and HGPRBMY11v2. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel HGPRBMY11, HGPRBMY11v1, and/or HGPRBMY11v2 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly cardiovascular diseases and/or disorders. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
Methods Of Diagnosing Colon Adenocarcinoma Using The Human G-Protein Coupled Receptor Hgprbmy23
US Patent:
7312086, Dec 25, 2007
Filed:
Feb 26, 2003
Appl. No.:
10/375157
Inventors:
John N. Feder - Belle Mead NJ, US
Thomas C. Nelson - Lawrenceville NJ, US
Chandra S. Ramanathan - Wallingford CT, US
Rolf-Peter Ryseck - Ewing NJ, US
Michael G. Neubauer - Skillman NJ, US
Thomas C. Nelson - Lawrenceville NJ, US
Chandra S. Ramanathan - Wallingford CT, US
Rolf-Peter Ryseck - Ewing NJ, US
Michael G. Neubauer - Skillman NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
G01N 33/48
US Classification:
436 64
Abstract:
The present invention provides novel polynucleotides encoding HGPRBMY23 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel HGPRBMY23 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly renal diseases and/or disorders, colon cancer, breast cancer, and diseases and disorders related to aberrant NFKB modulation. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
Polynucleotides Encoding Novel Cysteine Proteases Of The Calpain Superfamily, Can-12V1 And Can-12V2.
US Patent:
7186564, Mar 6, 2007
Filed:
Apr 3, 2002
Appl. No.:
10/116519
Inventors:
Jian Chen - Princeton NJ, US
Thomas C. Nelson - Lawrenceville NJ, US
Roy J. Vaz - North Branch NJ, US
Franck Duclos - Washington Crossing PA, US
Thomas C. Nelson - Lawrenceville NJ, US
Roy J. Vaz - North Branch NJ, US
Franck Duclos - Washington Crossing PA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C12N 15/57, C12N 9/64, C12N 15/74, C12N 15/79
US Classification:
436 232, 435 691, 435226, 4352523, 4353201
Abstract:
The present invention provides novel polynucleotides encoding CAN-12 polypeptides, fragments and homologues thereof. The present invention also provides polynucleotides encoding variants of CAN-12 polypeptides, CAN-12v1 and CAN-12v2. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel CAN-12, CAN-12v1, and CAN-12v2 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly neuro- and musculo-degenerative conditions. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
Polynucleotide Encoding A Novel Human Serpin Secreted From Lymphoid Cells, Lsi-01
US Patent:
7247717, Jul 24, 2007
Filed:
Nov 14, 2001
Appl. No.:
09/993180
Inventors:
Jian Chen - Princeton NJ, US
Thomas Nelson - Lawrenceville NJ, US
Daniel L. Cheney - Flemington NJ, US
Thomas Nelson - Lawrenceville NJ, US
Daniel L. Cheney - Flemington NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C12N 15/15, C12N 15/62, C12N 15/70, C12N 15/74, C12N 15/79
US Classification:
536 235, 435 692, 435 697, 4352523, 4353201, 536 234
Abstract:
The present invention provides novel polynucleotides encoding LSI-01 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel LSI-01 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
Novel Metalloprotease Polypeptide, Mp-1
US Patent:
2004004, Mar 11, 2004
Filed:
Aug 29, 2003
Appl. No.:
10/651722
Inventors:
Jian Chen - Princeton NJ, US
John Feder - Belle Mead NJ, US
Thomas Nelson - Lawrenceville NJ, US
Stanley Krystek - Ringoes NJ, US
Franck Duclos - Washington Crossing PA, US
John Feder - Belle Mead NJ, US
Thomas Nelson - Lawrenceville NJ, US
Stanley Krystek - Ringoes NJ, US
Franck Duclos - Washington Crossing PA, US
International Classification:
C12Q001/68, C07H021/04, C12N009/64, C12P021/02, C12N005/06
US Classification:
435/006000, 435/069100, 435/226000, 435/320100, 435/325000, 536/023200
Abstract:
The present invention provides novel polynucleotides encoding MP-1 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel MP-1 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
Novel Human G-Protein Coupled Receptor, Hgprbmy14, Related To The Orphan Gpcr, Gpr73
US Patent:
2003010, May 29, 2003
Filed:
Feb 5, 2002
Appl. No.:
10/067649
Inventors:
John Feder - Belle Mead NJ, US
Chandra Ramanathan - Wallingford CT, US
Thomas Nelson - Lawrenceville NJ, US
Michael Kornacker - Princeton NJ, US
Rolf-Peter Ryseck - Ewing NJ, US
Angela Cacace - Clinton CT, US
Lauren Barber - Jewett City CT, US
Chandra Ramanathan - Wallingford CT, US
Thomas Nelson - Lawrenceville NJ, US
Michael Kornacker - Princeton NJ, US
Rolf-Peter Ryseck - Ewing NJ, US
Angela Cacace - Clinton CT, US
Lauren Barber - Jewett City CT, US
International Classification:
C12P021/02, C12N005/06, C07K014/435, C07H021/04
US Classification:
435/069100, 435/183000, 435/320100, 435/325000, 536/023200, 530/350000
Abstract:
The present invention provides novel polynucleotides encoding HGPRBMY14 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel HGPRBMY14 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
Polynucleotides Encoding A Novel Metalloprotease, Mp-1
US Patent:
2004004, Mar 4, 2004
Filed:
Aug 27, 2003
Appl. No.:
10/649273
Inventors:
Jian Chen - Princeton NJ, US
John Feder - Belle Mead NJ, US
Thomas Nelson - Lawrenceville NJ, US
Stanley Krystek - Ringoes NJ, US
Franck Duclos - Washington Crossing PA, US
John Feder - Belle Mead NJ, US
Thomas Nelson - Lawrenceville NJ, US
Stanley Krystek - Ringoes NJ, US
Franck Duclos - Washington Crossing PA, US
International Classification:
C12Q001/68, C07H021/04, C12N009/64, C12P021/02, C12N005/06
US Classification:
435/006000, 435/069100, 435/226000, 435/320100, 435/325000, 536/023200
Abstract:
The present invention provides novel polynucleotides encoding MP-1 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel MP-1 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
G-Protein Coupled Receptor Nucleic Acids, Polypeptides, Antibodies And Uses Thereof
US Patent:
2003006, Apr 3, 2003
Filed:
Feb 22, 2002
Appl. No.:
10/081810
Inventors:
John Feder - Belle Mead NJ, US
Chandra Ramanathan - Wallingford CT, US
Thomas Nelson - Lawrenceville NJ, US
Gabriel Mintier - Hightstown NJ, US
Angela Cacace - Clinton CT, US
Lauren Barber - Jewett City CT, US
Michael Kornacker - Princeton NJ, US
David Bol - Langhorne PA, US
Chandra Ramanathan - Wallingford CT, US
Thomas Nelson - Lawrenceville NJ, US
Gabriel Mintier - Hightstown NJ, US
Angela Cacace - Clinton CT, US
Lauren Barber - Jewett City CT, US
Michael Kornacker - Princeton NJ, US
David Bol - Langhorne PA, US
International Classification:
C12P021/02, C12N005/06, C07H021/04, C07K014/435
US Classification:
435/069100, 536/023500, 530/350000, 435/320100, 435/325000
Abstract:
The invention provides isolated HGPRBMY1 and HGPRBMY2 nucleic acid molecules and polypeptide molecules. The invention also provides antisense nucleic acid molecules, expression vectors containing the nucleic acid molecules of the invention, host cells into which the expression vectors have been introduced, and non-human transgenic animals in which a nucleic acid molecule of the invention has been introduced or disrupted. The invention still further provides isolated polypeptides, fusion polypeptides, antigenic peptides and antibodies. Diagnostic, screening and therapeutic methods utilizing compositions of the invention are also provided.